Skip to content
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • Dividend
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • Dividend
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • Dividend
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • Dividend
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us

Digital Domain

Explore the digital sphere, where we connect and share our narratives, innovations and industry perspectives through online platforms.

Epigral posts Q2 FY24 consolidated PAT at Rs. 38 Cr

  • 7 November 2023

Indian chemicals maker Epigral expects revenue from newer products to surge this year

  • 21 September 2023

‘Meghmani Finechem Limited’ is now ‘Epigral Limited’

  • 7 September 2023

Meghmani Finechem Limited’ is now ‘Epigral Limited’

  • 7 September 2023

Epigral expands into CPVC Compounding

  • 31 August 2023

Epigral Ltd announces expansion into CPVC compounds

  • 31 August 2023

Epigral to Set up Plant to Manufacture CPVC Compound

  • 31 August 2023

Meghmani Finchem commissions 18.34 MW wind-solar hybrid power plant

  • 28 June 2023

Meghmani Finechem shines on commissioning of wind-solar power plant

  • 28 June 2023

Mr. Maulik Patel, CMD, in talks with Moneycontrol, MFL business prospects and capex plans

  • 16 May 2023

Meghmani Finechem FY23 PAT up 40% at Rs. 353 Cr, revenue jumps 41% to Rs. 2,188 Cr

  • 27 April 2023

Meghmani Finech Consolidated March 2023 Net Sales at Rs 562.18 crore, up 12.71% Y-o-Y

  • 26 April 2023

Meghmani Finechem Ltd consolidated Q4 FY2023 PAT lower at Rs. 76.73 crores

  • 25 April 2023

Meghmani Finechem FY23 PAT Up 40% At Rs 353 Cr

  • 25 April 2023

Meghmani Finechem FY23 PAT up 40% at Rs. 353 Cr

  • 25 April 2023

Mr. Maulik Patel, CMD, in talks with CXO Today, Chemicals to take India’s growth to another level

  • 30 March 2023

Decoding China Plus One for the Indian chemical sector – Mr. Maulik Patel, CMD, Meghmani Fienchem Ltd

  • 22 January 2023

Meghmani Finechem’s Q3FY23 revenue up 27%; PAT by 11%

  • 20 January 2023
Previous Page1 Page2 Page3 Page4 Page5 … Page7 Next

Explore our solutions – Connect with Epigral

Important Links

  • Chlor Alkali
  • Chloromethanes
  • Hydrogen Peroxide
  • Epichlorohydrin
  • Chlorotoluenes Value Chain
  • CPVC
  • About Us
  • Chlor Alkali
  • Chloromethanes
  • Hydrogen Peroxide
  • Epichlorohydrin
  • Chlorotoluenes Value Chain
  • CPVC
  • About Us

Quick Links

  • Results
  • Our Journey
  • Environment Health and Safety
  • Corporate Social Responsibility
  • Careers
  • Contact us
  • Results
  • Our Journey
  • Environment Health and Safety
  • Corporate Social Responsibility
  • Careers
  • Contact us

Contact

Monday-Saturday: 08am-9pm
+91 79 29709600

Want to email us instead?
in**@*****al.com

At Epigral, we are at the forefront of India’s chemical industry, bringing solutions by providing essential derivatives and specialty chemicals.

© 2026 Copyrights Epigral Limited. All Rights Reserved.